Arcturus Therapeutics Holdings (ARCT)
(Delayed Data from NSDQ)
$27.26 USD
+0.47 (1.75%)
Updated May 10, 2024 04:00 PM ET
After-Market: $27.24 -0.02 (-0.07%) 7:58 PM ET
4-Sell of 5 4
F Value F Growth F Momentum F VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
08/05/2024
Time: -- |
6/2024 | $-1.20 | -16.67% |
Earnings Summary
For their last quarter, Arcturus Therapeutics Holdings (ARCT) reported earnings of -$1.00 per share, beating the Zacks Consensus Estimate of $-1.17 per share. This reflects a positive earnings surprise of 14.53%. Look out for ARCT's next earnings release expected on August 05, 2024. For the next earning release, we expect the company to report earnings of -$1.20 per share, reflecting a year-over-year increase of 39.39%.
Earnings History
Price & Consensus
Zacks News for ARCT
Analysts Estimate Arcturus Therapeutics (ARCT) to Report a Decline in Earnings: What to Look Out for
ARCT: What are Zacks experts saying now?
Zacks Private Portfolio Services